Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CognitionMetrics is an active U.S.-based consulting firm specializing in the measurement of cognitive and behavioral change within pharmaceutical clinical trials. It operates as a service provider rather than a therapeutics developer—offering expertise that spans endpoint selection/design for studies involving neurology/psychiatry/general medicine populations where cognition matters most. CognitionMetrics provides expert consultation to pharmaceutical companies on measuring cognitive and behavioral changes in clinical trials. Their expertise includes computerized and non-computerized cognitive testing solutions, rating scale development/validation for diverse populations (juvenile to elderly), protocol design optimization, endpoint selection, data interpretation, and communication with regulatory/payer stakeholders. They support both internal R&D teams and conduct independent research to aid product development. There are no drugs under development nor any proprietary platforms reported by the company at this time.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CognitionMetrics.